FineImmu
Creating future health with advanced cell therapy drugs and precision immunodiagnostic products.
General Information
BounceWatch is an independent company data service, not affiliated with FineImmu. To contact FineImmu, visit fineimmu.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does FineImmu compare?
A PDF of FineImmu and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting FineImmu soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is FineImmu on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About FineImmu
Business keywords: cell therapy, immunotherapy, precision medicine, immunodiagnostic, PD-1, PD-L1, immune checkpoint inhibitors, cancer therapy, drug development, biopharmaceuticals
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | CNY90.00M | 4 |
|
03 Aug 2022 |
FineImmu Alternatives & Competitors
View All Alternatives
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic
Bringing Effective New Treatments And Options To Patients Who Need Them
We are a biopharmaceutical company committed to the discovery and development of mono- and combinati...
FAQ About FineImmu
Source: BounceWatch company record for FineImmu, https://bouncewatch.com/company/fineimmu, updated 27 December 2024. When citing, please name BounceWatch and link this page.
